Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

Clinical trial NCT03293524 · COMPLETED

Trial details

NCT number: NCT03293524
Sponsor: GenSight Biologics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leber Hereditary Optic Neuropathy

Start date: 2018-03-12
Primary completion: 2024-07-23
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.